Latest news and interviews for media and investors

Jan 08, 2024

Novartis is attending the 42nd Annual J.P. Morgan Healthcare Conference from January 8-11, 2024 in San Francisco, California.

Webcast recording

Highlights include:

  • Focused strategy
  • Robust pipeline
  • Attractive growth prospects
  • ESG leader

In the news

Vasant (Vas) Narasimhan, M.D., Chief Executive Officer (CEO)

Novartis CEO Vasant Narasimhan: The right story for the company was to focus on R&D

CNBC | Jan 9, 2024

JPM24: Novartis’ head start, FTC fallout and Bluebird’s price defense

Biopharma Dive | Jan 10, 2024

Read more

Novartis dances into JPM with $250M Calypso buyout, $185M RNAi alliance

Fierce Biotech | Jan 8, 2024

Read more

JPM24: As cancer players jump head-first into ADC field, Novartis CEO explains how he's resisted the temptation

Fierce Biotech | Jan 8, 2024

Read more

Novartis strikes $250M buyout for Merck Serono spinout's autoimmune 'pipeline-in-a-drug'

Endpoints News | Jan 8, 2024

Read more

Partner with Novartis

Connect with our Corporate & Business Development team and share your opportunities.

Learn more

Related links

Additional resources

J.P. Morgan Healthcare Conference official website